After an hesitant trading day on positive phase 3 data we comfirm today on strong volume. An analist upgrade and more news in 4quarter to expect makes 15 to 17$ a fair target.
just a couple weeks later and the stock has already given up half those gains. Starting to look like a good entry point.
this is the most promising stock in my portfolio-just took a bath on ARNA, thank God this stock is the real deal.